Carbonic anhydrase inhibitors. Part 71 - Synthesis and ocular pharmacologyof a new class of water-soluble, topically effective intraocular pressure lowering sulfonamides incorporating picolinoyl moieties
Ct. Supuran et al., Carbonic anhydrase inhibitors. Part 71 - Synthesis and ocular pharmacologyof a new class of water-soluble, topically effective intraocular pressure lowering sulfonamides incorporating picolinoyl moieties, EUR J PH SC, 8(4), 1999, pp. 317-328
Reaction of 20 aromatic/heterocyclic sulfonamides containing a free amino,
imino, hydrazino or hydroxyl group, with picolinic acid in the presence of
carbodiimide derivatives afforded a series of water-soluble (as hydrochlori
de or triflate salts) compounds. The new derivatives were assayed as inhibi
tors of three carbonic anhydrase (CA) isozymes, CA I, II (cytosolic forms)
and IV (membrane-bound form). Efficient inhibition was observed against all
three isozymes, but especially against CA II and CA IV (in nanomolar range
), the two isozymes known to play a critical role in aqueous humor secretio
n within the ciliary processes of the eye. Some of the best inhibitors synt
hesized were applied as 2% water solutions directly into the eye of normote
nsive or glaucomatous albino rabbits. Very strong intraocular pressure (IOP
) lowering was observed for many of them, and the active drug was detected
in eye tissues and fluids. This result prompted us to reanalyze the synthet
ic work done by other groups for the design of water soluble, topically eff
ective antiglaucoma sulfonamides. According to these researchers, the IOP l
owering effect is due to the intrinsic nature of the specific heterocyclic
sulfonamide considered, among which the thienothiopyran-2-suIfonamide deriv
atives represent the best studied case. Indeed, the first agents developed
for such applications, such as dorzolamide, are derivatives of this ring sy
stem. In order to prove that the tail (in this case the picolinoyl moiety)
conferring water solubility to a sulfonamide CA inhibitor is critically imp
ortant for its topical effectiveness, similarly to the ring to which the su
lfonamido group is grafted, we also prepared a dorzolamide derivative to wh
ich the picolinoyl moiety was attached. This new compound is more water sol
uble than dorzolamide (as hydrochloride salt), behaves as a strong CA II in
hibitor, and acts similarly to the parent derivative in lowering IOP in exp
erimental animals. Thus, it seems that the tail conferring water solubility
is more important for topical activity as antiglaucoma drug, than the hete
rocyclic/aromatic ring to which the sulfonamido moiety is grafted. (C) 1999
Elsevier Science B.V. All rights reserved.